Aktis Oncology, Inc. Common stock (AKTS NASDAQ) stock market data APIs
$20.1613
-0.18(-0.9%)
as of January 30, 2026
Try our APIs with
free plan!
Aktis Oncology, Inc. Common stock Financial Data Overview
Price chart is built with
Anychart
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.
Prev. Close
20.1613
Open
19.9816
High
20.2075
Low
19.2554
52 wk Range
18.52-29.16
Market Cap
1 121 M
Shares Outstanding
50 649 K
Revenue
5 560 K
EPS
-0.04
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aktis Oncology, Inc. Common stock data using free add-ons & libraries
Get Aktis Oncology, Inc. Common stock Fundamental Data
Aktis Oncology, Inc. Common stock Fundamental data includes:
- Net Revenue: 5 560 K
- EBITDA: -70 869 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-14
- EPS/Forecast: -0.08
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aktis Oncology, Inc. Common stock News
New
Should You Buy PICS Stock After the PicPay IPO?
2025 was a better year for IPOs than 2024. More than 200 companies raised about $33.6 billion, up from 150 companies and roughly $30 billion the year before. Although the tech theme dominated, thanks ...
Huge Insider Buying Now at This Insurance Giant and 2 Biotechs
In the past week, a beneficial owner has continued to build a stake in insurance giant W.R. Berkley Corp. (NYSE: WRB). And public offerings of shares of biotech firms Alumis Inc. (NASDAQ: ALMS) and Ak...
Assessing Aktis Oncology (AKTS) Valuation After IPO, NASDAQ Inclusion And Heavy Insider And Institutional Buying
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Aktis Oncology (AKTS) has j...
A Fresh IPO That Long-Term Investors Shouldn’t Ignore
AKTIS Oncology logo above a laboratory dish with glowing molecular particles, representing cancer research and drug development. Key Points While IPOs are often labeled as high-risk startups, some a...
Get Aktis Oncology, Inc. Common stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
